Scoggin Management LP Clene Inc. Transaction History
Scoggin Management LP
- $278 Million
- Q2 2024
A detailed history of Scoggin Management LP transactions in Clene Inc. stock. As of the latest transaction made, Scoggin Management LP holds 375,000 shares of CLNN stock, worth $2.2 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
375,000
Previous 500,000
25.0%
Holding current value
$2.2 Million
Previous $215,000
37.21%
% of portfolio
0.05%
Previous 0.08%
Shares
4 transactions
Others Institutions Holding CLNN
# of Institutions
40Shares Held
6.22MCall Options Held
287KPut Options Held
162K-
Vanguard Group Inc Valley Forge, PA2.62MShares$15.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA922KShares$5.41 Million0.0% of portfolio
-
Morgan Stanley New York, NY339KShares$1.99 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL273KShares$1.6 Million0.0% of portfolio
-
Csenge Advisory Group270KShares$1.58 Million0.01% of portfolio
About Clene Inc.
- Ticker CLNN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,502,000
- Market Cap $373M
- Description
- Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...